{
  "ticker": "VRTX",
  "last_updated": "2025-04-19T08:33:46.038115",
  "retention_years": 3,
  "count": 566,
  "transactions": [
    {
      "id": 140125,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "630",
      "transaction_price": "466.84",
      "transaction_type": "F",
      "shares_after_transaction": "17650"
    },
    {
      "id": 113666,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-08-30",
      "transaction_shares": "3784",
      "transaction_price": "499",
      "transaction_type": "S",
      "shares_after_transaction": "9994"
    },
    {
      "id": 113707,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-30",
      "transaction_shares": "646",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5081"
    },
    {
      "id": 140046,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-08-30",
      "transaction_shares": "3784",
      "transaction_price": "499",
      "transaction_type": "S",
      "shares_after_transaction": "9994"
    },
    {
      "id": 140088,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-30",
      "transaction_shares": "646",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5081"
    },
    {
      "id": 89165,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 113682,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 140063,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-08",
      "transaction_shares": "1292",
      "transaction_price": "152.74",
      "transaction_type": "M",
      "shares_after_transaction": "5727"
    },
    {
      "id": 89178,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 113695,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 140076,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-08-07",
      "transaction_shares": "2280",
      "transaction_price": "476.75",
      "transaction_type": "S",
      "shares_after_transaction": "23259"
    },
    {
      "id": 89222,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 113740,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 140121,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-08-01",
      "transaction_shares": "5295",
      "transaction_price": "125.71",
      "transaction_type": "M",
      "shares_after_transaction": "45295"
    },
    {
      "id": 89160,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 113677,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 140057,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-30",
      "transaction_shares": "15202",
      "transaction_price": "505",
      "transaction_type": "S",
      "shares_after_transaction": "90970"
    },
    {
      "id": 66992,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 89171,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 113688,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 140069,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-24",
      "transaction_shares": "2280",
      "transaction_price": "488.46",
      "transaction_type": "S",
      "shares_after_transaction": "25539"
    },
    {
      "id": 67035,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 89215,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 113733,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 140114,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-07-22",
      "transaction_shares": "15202",
      "transaction_price": "497",
      "transaction_type": "S",
      "shares_after_transaction": "106172"
    },
    {
      "id": 67029,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 89209,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 113727,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 140108,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-07-10",
      "transaction_shares": "2280",
      "transaction_price": "487.34",
      "transaction_type": "S",
      "shares_after_transaction": "27819"
    },
    {
      "id": 67020,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-26",
      "transaction_shares": "2280",
      "transaction_price": "471.72",
      "transaction_type": "S",
      "shares_after_transaction": "30099"
    },
    {
      "id": 89200,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-26",
      "transaction_shares": "2280",
      "transaction_price": "471.72",
      "transaction_type": "S",
      "shares_after_transaction": "30099"
    },
    {
      "id": 113718,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-26",
      "transaction_shares": "2280",
      "transaction_price": "471.72",
      "transaction_type": "S",
      "shares_after_transaction": "30099"
    },
    {
      "id": 140099,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-26",
      "transaction_shares": "2280",
      "transaction_price": "471.72",
      "transaction_type": "S",
      "shares_after_transaction": "30099"
    },
    {
      "id": 46873,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-12",
      "transaction_shares": "2280",
      "transaction_price": "478",
      "transaction_type": "S",
      "shares_after_transaction": "32379"
    },
    {
      "id": 66980,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-12",
      "transaction_shares": "2280",
      "transaction_price": "478",
      "transaction_type": "S",
      "shares_after_transaction": "32379"
    },
    {
      "id": 89157,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-12",
      "transaction_shares": "2280",
      "transaction_price": "478",
      "transaction_type": "S",
      "shares_after_transaction": "32379"
    },
    {
      "id": 113674,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-12",
      "transaction_shares": "2280",
      "transaction_price": "478",
      "transaction_type": "S",
      "shares_after_transaction": "32379"
    },
    {
      "id": 140054,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-06-12",
      "transaction_shares": "2280",
      "transaction_price": "478",
      "transaction_type": "S",
      "shares_after_transaction": "32379"
    },
    {
      "id": 46876,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-06-11",
      "transaction_shares": "6824",
      "transaction_price": "481.96",
      "transaction_type": "F",
      "shares_after_transaction": "23260"
    },
    {
      "id": 66983,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-06-11",
      "transaction_shares": "6824",
      "transaction_price": "481.96",
      "transaction_type": "F",
      "shares_after_transaction": "23260"
    },
    {
      "id": 89161,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-06-11",
      "transaction_shares": "6824",
      "transaction_price": "481.96",
      "transaction_type": "F",
      "shares_after_transaction": "23260"
    },
    {
      "id": 113678,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-06-11",
      "transaction_shares": "6824",
      "transaction_price": "481.96",
      "transaction_type": "F",
      "shares_after_transaction": "23260"
    },
    {
      "id": 140058,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-06-11",
      "transaction_shares": "6824",
      "transaction_price": "481.96",
      "transaction_type": "F",
      "shares_after_transaction": "23260"
    },
    {
      "id": 46919,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-06-05",
      "transaction_shares": "4600",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 67028,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-06-05",
      "transaction_shares": "4600",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 89208,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-06-05",
      "transaction_shares": "4600",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 113726,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-06-05",
      "transaction_shares": "4600",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 140107,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-06-05",
      "transaction_shares": "4600",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "0"
    },
    {
      "id": 46885,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-06-03",
      "transaction_shares": "2175",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "49098"
    },
    {
      "id": 46924,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-06-03",
      "transaction_shares": "3250",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "47137"
    },
    {
      "id": 66993,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-06-03",
      "transaction_shares": "2175",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "49098"
    },
    {
      "id": 67034,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-06-03",
      "transaction_shares": "3250",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "47137"
    },
    {
      "id": 89172,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-06-03",
      "transaction_shares": "2175",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "49098"
    },
    {
      "id": 89214,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-06-03",
      "transaction_shares": "3250",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "47137"
    },
    {
      "id": 113689,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-06-03",
      "transaction_shares": "2175",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "49098"
    },
    {
      "id": 113732,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-06-03",
      "transaction_shares": "3250",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "47137"
    },
    {
      "id": 140070,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-06-03",
      "transaction_shares": "2175",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "49098"
    },
    {
      "id": 140113,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-06-03",
      "transaction_shares": "3250",
      "transaction_price": "460",
      "transaction_type": "S",
      "shares_after_transaction": "47137"
    },
    {
      "id": 46866,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-05-30",
      "transaction_shares": "2350",
      "transaction_price": "439.11",
      "transaction_type": "S",
      "shares_after_transaction": "53523"
    },
    {
      "id": 66972,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-05-30",
      "transaction_shares": "2350",
      "transaction_price": "439.11",
      "transaction_type": "S",
      "shares_after_transaction": "53523"
    },
    {
      "id": 89149,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-05-30",
      "transaction_shares": "2350",
      "transaction_price": "439.11",
      "transaction_type": "S",
      "shares_after_transaction": "53523"
    },
    {
      "id": 113665,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-05-30",
      "transaction_shares": "2350",
      "transaction_price": "439.11",
      "transaction_type": "S",
      "shares_after_transaction": "53523"
    },
    {
      "id": 140045,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-05-30",
      "transaction_shares": "2350",
      "transaction_price": "439.11",
      "transaction_type": "S",
      "shares_after_transaction": "53523"
    },
    {
      "id": 46915,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "2280",
      "transaction_price": "445.56",
      "transaction_type": "S",
      "shares_after_transaction": "34659"
    },
    {
      "id": 67024,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "2280",
      "transaction_price": "445.56",
      "transaction_type": "S",
      "shares_after_transaction": "34659"
    },
    {
      "id": 89204,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "2280",
      "transaction_price": "445.56",
      "transaction_type": "S",
      "shares_after_transaction": "34659"
    },
    {
      "id": 113722,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "2280",
      "transaction_price": "445.56",
      "transaction_type": "S",
      "shares_after_transaction": "34659"
    },
    {
      "id": 140103,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-05-29",
      "transaction_shares": "2280",
      "transaction_price": "445.56",
      "transaction_type": "S",
      "shares_after_transaction": "34659"
    },
    {
      "id": 46920,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-05-28",
      "transaction_shares": "3250",
      "transaction_price": "454.79",
      "transaction_type": "S",
      "shares_after_transaction": "50387"
    },
    {
      "id": 67030,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-05-28",
      "transaction_shares": "3250",
      "transaction_price": "454.79",
      "transaction_type": "S",
      "shares_after_transaction": "50387"
    },
    {
      "id": 89210,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-05-28",
      "transaction_shares": "3250",
      "transaction_price": "454.79",
      "transaction_type": "S",
      "shares_after_transaction": "50387"
    },
    {
      "id": 113728,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-05-28",
      "transaction_shares": "3250",
      "transaction_price": "454.79",
      "transaction_type": "S",
      "shares_after_transaction": "50387"
    },
    {
      "id": 140109,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-05-28",
      "transaction_shares": "3250",
      "transaction_price": "454.79",
      "transaction_type": "S",
      "shares_after_transaction": "50387"
    },
    {
      "id": 46914,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-24",
      "transaction_shares": "1565",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "122939"
    },
    {
      "id": 67023,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-24",
      "transaction_shares": "1565",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "122939"
    },
    {
      "id": 89203,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-24",
      "transaction_shares": "1565",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "122939"
    },
    {
      "id": 113721,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-24",
      "transaction_shares": "1565",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "122939"
    },
    {
      "id": 140102,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-24",
      "transaction_shares": "1565",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "122939"
    },
    {
      "id": 29419,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 46904,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 67012,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 89192,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 113710,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 140091,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "SACHS BRUCE I",
      "reporting_owner_cik": "0001197036",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-22",
      "transaction_shares": "7073",
      "transaction_price": "93.51",
      "transaction_type": "M",
      "shares_after_transaction": "47073"
    },
    {
      "id": 29414,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 46899,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 67007,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 89187,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 113704,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 140085,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-05-20",
      "transaction_shares": "15202",
      "transaction_price": "447",
      "transaction_type": "S",
      "shares_after_transaction": "121374"
    },
    {
      "id": 29397,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 29407,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 29409,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 29441,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 46881,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 46892,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 46894,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 46931,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 66988,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 67000,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 67002,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 67042,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 89167,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 89180,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 89182,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 89223,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 113684,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 113697,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 113699,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 113741,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 140065,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-05-15",
      "transaction_shares": "32",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "55325"
    },
    {
      "id": 140078,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-05-15",
      "transaction_shares": "54",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 140080,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Schneider Jennifer",
      "reporting_owner_cik": "0001783060",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-15",
      "transaction_shares": "922",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "922"
    },
    {
      "id": 140122,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-05-15",
      "transaction_shares": "69",
      "transaction_price": "430.93",
      "transaction_type": "S",
      "shares_after_transaction": "49691"
    },
    {
      "id": 29435,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 46925,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 67036,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 89216,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 113734,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 140115,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-05-14",
      "transaction_shares": "14112",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "30084"
    },
    {
      "id": 29388,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 29422,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 29423,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 29430,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 29442,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 46870,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 46907,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 46908,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 46917,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 46932,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 66976,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 67015,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 67016,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 67026,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 67043,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 89153,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 89195,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 89196,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 89206,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 89224,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 113670,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 113713,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 113714,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 113724,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 113742,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 140050,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Thornberry Nancy",
      "reporting_owner_cik": "0001797826",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "501",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "1637"
    },
    {
      "id": 140094,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "CARNEY LLOYD",
      "reporting_owner_cik": "0001204424",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "6319"
    },
    {
      "id": 140095,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "MCKENZIE DIANA",
      "reporting_owner_cik": "0001754648",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3604"
    },
    {
      "id": 140105,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "4902"
    },
    {
      "id": 140123,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Upadhyay Suketu",
      "reporting_owner_cik": "0001533149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-01",
      "transaction_shares": "1001",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "3727"
    },
    {
      "id": 16066,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 29395,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 46879,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 66986,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 89164,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 113681,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 140062,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "225",
      "transaction_price": "418.10",
      "transaction_type": "F",
      "shares_after_transaction": "7740"
    },
    {
      "id": 5364,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 5373,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 5376,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 5380,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 5381,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 5388,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 5389,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 5392,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 5399,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 16068,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 16078,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 16081,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 16085,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 16086,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 16093,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 16094,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 16097,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 16104,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 29398,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 29410,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 29413,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 29418,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 29420,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 29431,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 29432,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 29436,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 29446,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 46882,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 46895,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 46898,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 46903,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 46905,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 46918,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 46921,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 46926,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 46936,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 66989,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 67003,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 67006,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 67011,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 67013,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 67027,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 67031,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 67037,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 67047,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 89168,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 89183,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 89186,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 89191,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 89193,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 89207,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 89211,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 89217,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 89228,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 113685,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 113700,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 113703,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 113709,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 113711,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 113725,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 113729,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 113735,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 113746,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 140066,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "36939"
    },
    {
      "id": 140081,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3970",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "30052"
    },
    {
      "id": 140084,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-23",
      "transaction_shares": "2469",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "58329"
    },
    {
      "id": 140090,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "828",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "8848"
    },
    {
      "id": 140092,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-23",
      "transaction_shares": "9386",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "136507"
    },
    {
      "id": 140106,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "1654",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "16855"
    },
    {
      "id": 140110,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "56158"
    },
    {
      "id": 140116,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-23",
      "transaction_shares": "4714",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "54725"
    },
    {
      "id": 140128,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-23",
      "transaction_shares": "3309",
      "transaction_price": "431.79",
      "transaction_type": "F",
      "shares_after_transaction": "53583"
    },
    {
      "id": 5363,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 5367,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 5384,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 5390,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 5396,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 16067,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 16071,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 16089,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 16095,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 16101,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 29396,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 29401,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 29426,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 29433,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 29440,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 46880,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 46886,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 46911,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 46922,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 46930,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 66987,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 66994,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 67019,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 67032,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 67041,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 89166,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 89173,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 89199,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 89212,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 89221,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 113683,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 113690,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 113717,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 113730,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 113739,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 140064,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "360",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59467"
    },
    {
      "id": 140071,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3603",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "59439"
    },
    {
      "id": 140098,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3002",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "34022"
    },
    {
      "id": 140111,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-21",
      "transaction_shares": "3191",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "60798"
    },
    {
      "id": 140120,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-21",
      "transaction_shares": "1201",
      "transaction_price": "421.77",
      "transaction_type": "S",
      "shares_after_transaction": "18509"
    },
    {
      "id": 19,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 5377,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 16082,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 29415,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 46900,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 67008,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 89188,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 113705,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 140086,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-20",
      "transaction_shares": "4118",
      "transaction_price": "420.58",
      "transaction_type": "F",
      "shares_after_transaction": "13778"
    },
    {
      "id": 1,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 2,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 4,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 5,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 8,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 10,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 16,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 17,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 5354,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 5355,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 5357,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 5358,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 5361,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 5365,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 5372,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 5374,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 16057,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 16058,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 16060,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 16061,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 16064,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 16069,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 16077,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 16079,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 29383,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 29384,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 29387,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 29389,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 29393,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 29399,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 29408,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 29411,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 46864,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 46865,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 46869,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 46871,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 46877,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 46883,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 46893,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 46896,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 66970,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 66971,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 66975,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 66977,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 66984,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 66990,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 67001,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 67004,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 89147,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 89148,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 89152,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 89154,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 89162,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 89169,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 89181,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 89184,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 113663,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 113664,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 113669,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 113671,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 113679,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 113686,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 113698,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 113701,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 140043,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3498",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "70866"
    },
    {
      "id": 140044,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43060"
    },
    {
      "id": 140049,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "1501",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "21636"
    },
    {
      "id": 140051,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-16",
      "transaction_shares": "9359",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "152912"
    },
    {
      "id": 140059,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "59704"
    },
    {
      "id": 140067,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "3750",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "43838"
    },
    {
      "id": 140079,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "63680"
    },
    {
      "id": 140082,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4499",
      "transaction_price": "424.01",
      "transaction_type": "F",
      "shares_after_transaction": "71219"
    },
    {
      "id": 24,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 5385,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 16090,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 29427,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 46912,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 67021,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 89201,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 113719,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 140100,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-14",
      "transaction_shares": "4356",
      "transaction_price": "419.04",
      "transaction_type": "S",
      "shares_after_transaction": "22551"
    },
    {
      "id": 7,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 5360,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 16063,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 29392,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 46875,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 66982,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 89159,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 113676,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 140056,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-12",
      "transaction_shares": "2009",
      "transaction_price": "419.22",
      "transaction_type": "S",
      "shares_after_transaction": "28291"
    },
    {
      "id": 9,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 11,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 12,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 18,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 20,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 21,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 23,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 27,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 29,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 30,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 5362,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 5366,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 5368,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 5375,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 5378,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 5379,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 5383,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 5391,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 5394,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 5395,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 16065,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 16070,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 16072,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 16080,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 16083,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 16084,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 16088,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 16096,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 16099,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 16100,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 29394,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 29400,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 29402,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 29412,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 29416,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 29417,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 29424,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 29434,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 29438,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 29439,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 46878,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 46884,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 46887,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 46897,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 46901,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 46902,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 46909,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 46923,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 46928,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 46929,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 66985,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 66991,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 66995,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 67005,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 67009,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 67010,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 67017,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 67033,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 67039,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 67040,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 89163,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 89170,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 89174,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 89185,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 89189,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 89190,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 89197,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 89213,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 89219,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 89220,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 113680,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 113687,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 113691,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 113702,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 113706,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 113708,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 113715,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 113731,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 113737,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 113738,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 140060,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "68493"
    },
    {
      "id": 140068,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-09",
      "transaction_shares": "832",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "24050"
    },
    {
      "id": 140072,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2607",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "63454"
    },
    {
      "id": 140083,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2100",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "46810"
    },
    {
      "id": 140087,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "3177",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "80013"
    },
    {
      "id": 140089,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "1588",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "20018"
    },
    {
      "id": 140096,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-09",
      "transaction_shares": "8255",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "162271"
    },
    {
      "id": 140112,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2022",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "77586"
    },
    {
      "id": 140118,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-09",
      "transaction_shares": "591",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "11050"
    },
    {
      "id": 140119,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-09",
      "transaction_shares": "2099",
      "transaction_price": "422.74",
      "transaction_type": "F",
      "shares_after_transaction": "50733"
    },
    {
      "id": 25,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 5386,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 16091,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 29428,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 46913,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 67022,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 89202,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 113720,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 140101,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-08",
      "transaction_shares": "2698",
      "transaction_price": "421.73",
      "transaction_type": "F",
      "shares_after_transaction": "38348"
    },
    {
      "id": 3,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 6,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 13,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 14,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 15,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 22,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 26,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 28,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 31,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 32,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 33,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 5356,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 5359,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 5369,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 5370,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 5371,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 5382,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 5387,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 5393,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 5397,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 5398,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 5400,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 16059,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 16062,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 16073,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 16074,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 16076,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 16087,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 16092,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 16098,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 16102,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 16103,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 16105,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 29385,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 29390,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 29403,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 29404,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 29406,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 29421,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 29429,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 29437,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 29444,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 29445,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 29447,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 46867,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 46872,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 46888,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 46889,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 46891,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 46906,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 46916,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 46927,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 46934,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 46935,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 46937,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 66973,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 66978,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 66996,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 66997,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 66999,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 67014,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 67025,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 67038,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 67045,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 67046,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 67048,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 89150,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 89155,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 89175,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 89176,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 89179,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 89194,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 89205,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 89218,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 89226,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 89227,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 89229,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 113667,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 113672,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 113692,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 113693,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 113696,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 113712,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 113723,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 113736,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 113744,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 113745,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 113747,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    },
    {
      "id": 140047,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bozic Carmen",
      "reporting_owner_cik": "0001790029",
      "reporting_owner_position": "EVP and CMO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "35116"
    },
    {
      "id": 140052,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "63532"
    },
    {
      "id": 140073,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37852"
    },
    {
      "id": 140074,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2024-02-06",
      "transaction_shares": "10464",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12887"
    },
    {
      "id": 140077,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Atkinson Edward Morrow III",
      "reporting_owner_cik": "0001914164",
      "reporting_owner_position": "EVP, Chief Technical Ops. Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2326",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16205"
    },
    {
      "id": 140093,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6976",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "55613"
    },
    {
      "id": 140104,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49507"
    },
    {
      "id": 140117,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "6294",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "16863"
    },
    {
      "id": 140126,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-02-06",
      "transaction_shares": "14516",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "123227"
    },
    {
      "id": 140127,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Ambrose Kristen",
      "reporting_owner_cik": "0001856587",
      "reporting_owner_position": "SVP & Chief Accounting Officer",
      "transaction_date": "2024-02-06",
      "transaction_shares": "2950",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "9788"
    },
    {
      "id": 140129,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sachdev Amit",
      "reporting_owner_cik": "0001406338",
      "reporting_owner_position": "EVP Chief Patient & Ext Af Off",
      "transaction_date": "2024-02-06",
      "transaction_shares": "5814",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "64628"
    }
  ]
}